Theoretical concerns include: GHK-Cu angiogenic properties potentially conflicting with calcineurin inhibitor mechanisms
(trimrx.com) What to Do if the Color Is Wrong If you discover that your medication is cloudy, discolored, or contains particles, do not use it
Metabolites , 13 (4), 465
See the Semax peptide benefits complete guide for Semax mechanism details
Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort